What's happening in peptides this week.
We translate research papers, industry moves, and safety alerts into clear, helpful summaries.
New study suggests BPC-157 may support tendon recovery
Researchers report measurable improvements in animal models of tendon healing.
Helix Bio publishes lab results for every product in its 2026 catalog
A growing number of vendors now publish independent Certificates of Analysis (COAs).
Several fake websites are copying the look of real peptide vendors
Watch the domain name carefully — clones often differ by one letter.
Tirzepatide shows stronger long-term metabolic results in new analysis
A multi-year review compares two generations of GLP-1 peptides.
FDA opens public comment on GLP-1 compounding standards
Regulators want input on how compounded versions of GLP-1 peptides are made and labeled.
GHK-Cu skincare research roundup: what we actually know in 2026
Copper peptides have a long research history. Here is the plain-English version.
Underdosed BPC-157 batch reported across three reseller sites
Independent testing shows multiple batches measuring far below label claims.
MOTS-c and mitochondria: what the 2026 literature actually says
A friendly tour through a peptide that gets a lot of hype but limited human data.
Semaglutide cardiovascular outcomes: 5-year follow-up
Long-term data from a major trial shows sustained reductions in major adverse cardiac events.
Tirzepatide vs semaglutide: head-to-head data lands
SURMOUNT-5 directly compares the two leading GLP-1 class drugs for weight loss.
CJC-1295 modestly improves deep sleep, small study finds
A pilot study tracked sleep architecture across 30 healthy adults using polysomnography.
Meta-analysis: tesamorelin reduces visceral fat in HIV-associated lipodystrophy
Pooled data from seven trials confirms a consistent visceral fat reduction.
GHK-Cu shows faster wound closure in diabetic foot ulcer pilot
A small pilot study suggests topical GHK-Cu may accelerate closure rates.
Health authorities warn against Melanotan II amid hospitalization reports
Multiple European agencies have re-issued warnings following a cluster of serious adverse events.
Reviewing DSIP: what 40 years of sleep research actually shows
Delta sleep-inducing peptide has been studied since the 1970s, but evidence remains mixed.
Selank shows modest anxiety reduction in small Russian trial
A 60-patient trial compared intranasal Selank to a benzodiazepine and to placebo.
Semax may aid cognitive recovery after ischemic stroke
A new trial follows 120 stroke patients over six months of intranasal Semax treatment.
Thymosin Alpha-1 reduces severe infections in elderly cohort
A two-year observational study followed 800 nursing home residents.
Epitalon and telomeres: what the lab data actually shows
Most claims trace back to a small set of studies. We look at what they say.
Pooled analysis: AOD-9604 shows no meaningful fat loss vs placebo
A six-trial meta-analysis pours cold water on a popular marketing claim.
KPV reduces inflammatory markers in early IBD trial
A 60-patient pilot study tested oral KPV in patients with mild ulcerative colitis.
Counterfeit GLP-1 vials surge across European borders
Customs seizures of fake semaglutide and tirzepatide have nearly doubled this year.
FDA updates compounding rules for GLP-1 class drugs
New guidance narrows what compounders can produce and how they must label it.
How to read a peptide Certificate of Analysis (COA)
A line-by-line walkthrough of what each section actually tells you.
Storage and reconstitution: a practical beginner's guide
How to handle, mix, and store research peptides without degrading them.
Subcutaneous vs intramuscular: which route, when, and why
Different peptides — and different goals — favor different injection routes.
FDA warning letter targets large peptide compounder
A widely used compounder was cited for sterility and sourcing violations.
Apex Labs launches public COA verification portal
Customers can now scan a QR code on every vial to view third-party lab results.
Pure Peptides cuts prices across research line
A 15-25% price reduction follows new supplier agreements.
Meta-analysis: GLP-1 class effects on cardiovascular and renal outcomes
A new pooled analysis covers 14 trials and over 90,000 participants.
Retatrutide phase 2: largest weight loss reported in any class to date
A triple-agonist produces ~24% mean weight loss over 48 weeks.
MOTS-c and exercise: how a mitochondrial peptide may amplify training adaptations
A new review summarizes evidence on MOTS-c as an exercise mimetic.
SS-31 (elamipretide) shows benefit in heart failure subgroup
A subgroup analysis of a phase 3 trial finds improvement in cardiomyopathy patients.
Cycling vs continuous use: does it actually matter?
A look at where 'cycling' makes sense and where it's mostly tradition.
PT-141 (bremelanotide) post-marketing follow-up data
Five years of post-approval safety data is summarized in a new review.
Hexarelin's cardiac effects: a closer look
Animal studies show direct cardiac actions independent of GH release.
A mid-tier vendor announces shutdown after compliance review
Customers have 30 days to download COAs and finalize outstanding orders.
NAD+ precursors vs peptide 'energy' protocols: what the evidence says
Two popular approaches to 'cellular energy' compared head-to-head in the literature.
Best peptide for weight loss in 2026: an honest, plain-English guide
GLP-1 peptides like semaglutide, tirzepatide, and retatrutide dominate weight-loss research — here's what actually works, what's hype, and how to think about safety.
Best peptide for healing: BPC-157, TB-500, and what the research actually shows
BPC-157 and TB-500 are the two most-discussed healing peptides. Here's what current research supports, what it doesn't, and how to evaluate them honestly.
Best peptide for recovery after training, surgery, or injury
From BPC-157 for soft tissue to CJC-1295 / Ipamorelin for sleep-driven recovery — a practical comparison of recovery peptides.
Best peptide for anti-aging: Epitalon, MOTS-c, and the longevity short list
Epitalon, MOTS-c, GHK-Cu, and thymosin alpha-1 are the four peptides longevity researchers actually study. Here's what the data supports.
Best peptide for muscle growth: GH secretagogues, IGF-1 LR3, and honest expectations
CJC-1295, Ipamorelin, Sermorelin, and IGF-1 LR3 are the names that come up for muscle. Here's how they actually compare to training and nutrition.
Best peptide for sleep: DSIP, CJC-1295 / Ipamorelin, and what actually moves the needle
Sleep peptides are quieter than weight-loss peptides — but for many people the impact on daily life is bigger. Here's the honest short list.
Best peptide for skin: GHK-Cu, Matrixyl, and the evidence behind cosmetic peptides
GHK-Cu is the most-researched skin peptide. Here's what's well-supported, what's marketing, and how injectable and topical compare.
Best peptide stack: how experienced users actually combine peptides safely
Stacking peptides isn't about picking the most — it's about picking complementary mechanisms with minimal overlap and clean safety signals.
Best peptide for joints: BPC-157, TB-500, and joint-specific protocols
Joint pain is a stack of cartilage, ligament, tendon, and inflammation issues. Here's how the right peptides actually help.
Best peptide for inflammation: BPC-157, KPV, Thymosin Alpha-1, and how they differ
Three peptides dominate the anti-inflammatory conversation. Here's how they work, where they help, and the safety profile of each.
Are peptides safe? An honest breakdown by category and use case
Peptide safety depends entirely on which peptide, what dose, what source, and what monitoring. Here's an honest, category-by-category review.
Peptide side effects: the most common ones, by peptide and by category
From mild injection-site redness to GLP-1 nausea to potential growth-related concerns, here's a clear breakdown of what to actually expect.
BPC-157 side effects: what the research actually shows
BPC-157 has one of the cleanest safety profiles in the research peptide space — but 'clean in animals' doesn't mean 'risk-free in humans.' Here's what's known.
TB-500 dangers: separating real concerns from internet panic
TB-500 is generally well-tolerated, but a few real concerns deserve attention. Here's a calm, evidence-based review.
Peptide cancer risk: which peptides have real concerns and why
Cancer risk varies dramatically across peptides. Here's a careful, mechanism-based look at where the concerns are real, theoretical, or overblown.
Are research peptides legal? A jurisdiction-by-jurisdiction overview
The legality of research peptides depends entirely on where you live and how the product is marketed. Here's a clear, non-legal-advice overview.
FDA peptide warning: what the 503A list changes actually mean
The FDA's recent changes to the 503A compounding list confused a lot of buyers. Here's what actually changed and what it means in practice.
BPC-157 vs TB-500: which healing peptide should you actually pick?
Both are 'healing peptides,' but they work differently, dose differently, and excel in different situations. Here's a clear side-by-side.
Semaglutide vs tirzepatide: which GLP-1 peptide wins for weight loss?
Tirzepatide outperforms semaglutide in head-to-head weight loss trials — but the right choice depends on more than raw numbers.
Tirzepatide vs retatrutide: how the next-generation GLP-1 actually compares
Retatrutide adds a third receptor target on top of tirzepatide's dual mechanism. Early data is striking — here's the honest read.
Peptides vs HGH: why most informed users now skip exogenous HGH
Exogenous HGH dominated bodybuilding and longevity circles for decades. GH-secretagogue peptides have quietly replaced it for most informed users — here's why.
Best GLP-1 peptide in 2026: a clear ranking of semaglutide, tirzepatide, and retatrutide
All three GLP-1 peptides reduce body weight, but they don't perform identically. Here's a clear ranking by goal, access, and side effects.